Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Healthcare
Create a narrative
Australian Clinical Labs
ASX:ACL Community
Create a narrative
Australian Clinical Labs
Undervalued
Overvalued
Australian Clinical Labs
WA
Analyst Price Target
Consensus Narrative from 7 Analysts
Operational Improvements And New Genomic Tests Aim To Improve Future Outlook
Key Takeaways Improving collection centers and digital transformations are set to enhance operational efficiency, boosting profit margins and supporting revenue growth. New genomic tests with Geneseq and a recovering healthcare market may significantly increase revenue and drive growth domestically and internationally.
View narrative
AU$3.89
FV
6.5% undervalued
intrinsic discount
5.02%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
ACL
Australian Clinical Labs
Your Fair Value
AU$
Current Price
AU$3.64
7.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-24m
996m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$877.9m
Earnings AU$30.2m
Advanced
Set as Fair Value